An Observational, Prospective, Multicenter Study to Assess the Continuation Rates and User Acceptability of Bleeding Profile in First-time Users of Low-dose LNG-IUS
Latest Information Update: 18 May 2023
At a glance
- Drugs Levonorgestrel (Primary)
- Indications Pregnancy
- Focus Therapeutic Use
- Acronyms CORA
- Sponsors Bayer
- 15 May 2023 Status changed from active, no longer recruiting to completed.
- 30 Mar 2023 Planned End Date changed from 28 Feb 2023 to 11 Apr 2023.
- 17 Feb 2023 Planned End Date changed from 28 Jan 2023 to 28 Feb 2023.